Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal of Surgical Oncology
|
July 17, 2024
Survival benefit associated with screening of patients at elevated risk for pancreatic cancer
William J Kane, Kathleen R Haden, Elizabeth N Martin, et al.
Plos One
|
November 9, 2013
Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens
Dustin M Walters, Jayme B Stokes, Sara J Adair, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2020
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
Xiaolong Wei, Jiekun Yang, Sara J Adair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Alex D Michaels, Timothy E Newhook, Sara J Adair, et al.
Molecular Cancer Therapeutics
|
September 10, 2011
Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment
Jayme B Stokes, Sara J Adair, Jill K Slack-Davis, et al.
Neoplasia (New York, N.Y.)
|
February 27, 2013
Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib
Dustin M Walters, James M Lindberg, Sara J Adair, et al.
Nature Communications
|
October 17, 2018
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
Karol Szlachta, Cem Kuscu, Turan Tufan, et al.
Zebrafish
|
April 15, 2024
An Undergraduate Course in CRISPR/Cas9-Mediated Gene Editing in Zebrafish
Renu Srivastava, Connor W Davison, Abigail G Krull, et al.
Journal of Neurosurgery
|
February 10, 2018
Factors associated with burnout among US neurosurgery residents: a nationwide survey
Frank J Attenello, Ian A Buchanan, Timothy Wen, et al.
Cancer Research
|
March 12, 2024
A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer
Brooke A Brown, Paul J Myers, Sara J Adair, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal of Surgical Oncology
|
July 17, 2024
Survival benefit associated with screening of patients at elevated risk for pancreatic cancer
William J Kane, Kathleen R Haden, Elizabeth N Martin, et al.
Plos One
|
November 9, 2013
Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens
Dustin M Walters, Jayme B Stokes, Sara J Adair, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2020
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
Xiaolong Wei, Jiekun Yang, Sara J Adair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Alex D Michaels, Timothy E Newhook, Sara J Adair, et al.
Molecular Cancer Therapeutics
|
September 10, 2011
Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment
Jayme B Stokes, Sara J Adair, Jill K Slack-Davis, et al.
Neoplasia (New York, N.Y.)
|
February 27, 2013
Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib
Dustin M Walters, James M Lindberg, Sara J Adair, et al.
Nature Communications
|
October 17, 2018
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
Karol Szlachta, Cem Kuscu, Turan Tufan, et al.
Zebrafish
|
April 15, 2024
An Undergraduate Course in CRISPR/Cas9-Mediated Gene Editing in Zebrafish
Renu Srivastava, Connor W Davison, Abigail G Krull, et al.
Journal of Neurosurgery
|
February 10, 2018
Factors associated with burnout among US neurosurgery residents: a nationwide survey
Frank J Attenello, Ian A Buchanan, Timothy Wen, et al.
Cancer Research
|
March 12, 2024
A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer
Brooke A Brown, Paul J Myers, Sara J Adair, et al.
Page
of 7